Scientists probe Gut's role in silent liver epidemic
NCT ID NCT07313007
Summary
This study aims to understand how gut bacteria might contribute to fatty liver disease (MASLD) by producing specific substances. Researchers will analyze stool and blood samples from 24 participants—some with MASLD and some healthy—to measure these bacterial products and identify which bacteria make them. The goal is to gather knowledge that could lead to new treatment approaches in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Lyon Sud Service Endocrinologie, Diabète et nutrition
Pierre-Bénite, 69495, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.